HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Baldo, A. Articles by Cianflone, K. Search for Related Content PubMed PubMed Citation Articles by Baldo, A. Articles by Cianflone, K. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1415-1426, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C

A Baldo, AD Sniderman, S St Luce, XJ Zhang and K Cianflone
McGill Unit for the Prevention of Cardiovascular Disease, McGill University, Royal Victoria Hospital, Montreal, Canada.

Acylation Stimulating Protein (ASP) was recently purified to homogeneity from human plasma and shown to be identical to C3adesArg. ASP stimulates triglycerides synthesis in human skin fibroblasts and primary human adipocytes. In vitro differentiation of human preadipocytes to mature fat cells results in increased expression and accumulation of ASP in the medium. These differentiated human adipocytes are also much more responsive to ASP than preadipocytes. The object of this study was to investigate the signal transduction pathway by which ASP causes triglyceride synthesis (TGS) to increase in human cultured fibroblasts and adipocytes. No evidence was found for a protein kinase A-mediated response. ASP action was consistent with a protein kinase C (PKC)-mediated pathway in that: 1) the effect of ASP on TGS was mimicked by 1-10 nM phorbol 12-myristate 13-acetate (PMA), a potent activator of PKC; (202% ASP vs. 178% PMA stimulation); 2) the effect of PMA and ASP were non-additive with respect to TGS; 3) staurosporine (50 nM) and GF109203X (bisindolymaleimide) at 1 microM, both competitive inhibitors of the ATP-binding site on PKC, inhibited both ASP and PMA stimulation of TGS (-59% and -65% for ASP and -84% and -99% for PMA, respectively); 4) Calphostin C (0.8 microM) which interacts with the regulatory domain of PKC also inhibited the ASP- and PMA-mediated stimulation of PKC (-76% +/- 11% inhibition for ASP and - 99% +/- 20% inhibition for PMA), although in all cases the inhibition of PMA-stimulated triglyceride synthesis was greater; 5) ASP caused a time-dependent increase in intracellular diacylglycerol accumulation; and finally 6) stimulation by ASP caused an increase in PKC activity and a time-dependent translocation of PKC (maximal effect at 30 min) from the soluble intracellular compartment to a membrane-bound fraction (basal activity 22% in the membrane-bound fraction, ASP 54%, P < 0.05 and PMA 69% P < 0.0025). Taken together, the data are consistent with the conclusion that ASP acts to stimulate triglyceride synthesis via activation of the protein kinase C pathway.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Johswich, M. Martin, J. Thalmann, C. Rheinheimer, P. N. Monk, and A. Klos Ligand Specificity of the Anaphylatoxin C5L2 Receptor and Its Regulation on Myeloid and Epithelial Cell Lines J. Biol. Chem., December 22, 2006; 281(51): 39088 - 39095. [Abstract] [Full Text] [PDF]

				M. Marcil, H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest Jr, and K. Cianflone Identification of a Novel C5L2 Variant (S323I) in a French Canadian Family With Familial Combined Hyperlipemia Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1619 - 1625. [Abstract] [Full Text] [PDF]

				M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone Targeting the signaling pathway of acylation stimulating protein J. Lipid Res., March 1, 2006; 47(3): 643 - 652. [Abstract] [Full Text] [PDF]

				P. Hegyi, Z. Rakonczay Jr., L. Tiszlavicz, A. Varro, A. Toth, G. Racz, G. Varga, M. A. Gray, and B. E. Argent Protein kinase C mediates the inhibitory effect of substance P on HCO3- secretion from guinea pig pancreatic ducts Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1030 - C1041. [Abstract] [Full Text] [PDF]

				J. L. Miner The adipocyte as an endocrine cell J Anim Sci, March 1, 2004; 82(3): 935 - 941. [Abstract] [Full Text] [PDF]

				Z. Xia, K. L. Stanhope, E. Digitale, O.-M. Simion, L. Chen, P. Havel, and K. Cianflone Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice J. Biol. Chem., February 6, 2004; 279(6): 4051 - 4057. [Abstract] [Full Text] [PDF]

				D. Kalant, S. A. Cain, M. Maslowska, A. D Sniderman, K. Cianflone, and P. N. Monk The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein J. Biol. Chem., March 21, 2003; 278(13): 11123 - 11129. [Abstract] [Full Text] [PDF]

				Z. Xia, A. D. Sniderman, and K. Cianflone Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice J. Biol. Chem., November 22, 2002; 277(48): 45874 - 45879. [Abstract] [Full Text] [PDF]

				I. Murray, P. J. Havel, A. D. Sniderman, and K. Cianflone Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein Endocrinology, March 1, 2000; 141(3): 1041 - 1049. [Abstract] [Full Text] [PDF]

				I. Murray, A. D. Sniderman, and K. Cianflone Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance J. Lipid Res., September 1, 1999; 40(9): 1671 - 1676. [Abstract] [Full Text]

				I. Murray, A. D. Sniderman, and K. Cianflone Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E474 - E480. [Abstract] [Full Text] [PDF]

				V. Van Harmelen, S. Reynisdottir, K. Cianflone, E. Degerman, J. Hoffstedt, K. Nilsell, A. Sniderman, and P. Arner Mechanisms Involved in the Regulation of Free Fatty Acid Release from Isolated Human Fat Cells by Acylation-stimulating Protein and Insulin J. Biol. Chem., June 25, 1999; 274(26): 18243 - 18251. [Abstract] [Full Text] [PDF]

				J. Saleh, N. Christou, and K. Cianflone Regional specificity of ASP binding in human adipose tissue Am J Physiol Endocrinol Metab, May 1, 1999; 276(5): E815 - E821. [Abstract] [Full Text] [PDF]

				T. Scantlebury, M. Maslowska, and K. Cianflone Chylomicron-specific Enhancement of Acylation Stimulating Protein and Precursor Protein C3 Production in Differentiated Human Adipocytes J. Biol. Chem., August 14, 1998; 273(33): 20903 - 20909. [Abstract] [Full Text] [PDF]

				J. Saleh, L. K. M. Summers, K. Cianflone, B. A. Fielding, A. D. Sniderman, and K. N. Frayn Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period J. Lipid Res., April 1, 1998; 39(4): 884 - 891. [Abstract] [Full Text]

				A. D. Sniderman, K. Cianflone, P. Arner, L. K. M. Summers, and K. N. Frayn The Adipocyte, Fatty Acid Trapping, and Atherogenesis Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 147 - 151. [Full Text] [PDF]